Results
184
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
184 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$29.57 | -3.6% | 87.6% | US$5.0b | US$30.33 | PS25.3x | E60.9% | n/a | Semiconductors | ||
EH | US$13.58 | -11.4% | -21.6% | US$923.3m | US$24.98 | PS39.8x | E74.3% | n/a | Capital Goods | ||
ATAT | US$16.93 | -10.8% | -9.0% | US$2.4b | US$27.17 | PE17.3x | E22.1% | 0.9% | Consumer Services | ||
GCT | US$29.23 | -6.5% | 251.3% | US$1.2b | US$53.22 | PE11.4x | E25.2% | n/a | Retail | ||
VCTR | US$51.91 | 3.4% | 51.2% | US$3.4b | US$52.00 | PE15.3x | E34.0% | 2.9% | Diversified Financials | ||
PDD | US$132.08 | -5.1% | 76.4% | US$183.1b | US$207.21 | PE16.7x | E21.4% | n/a | Retail | ||
TBBB | US$26.01 | 2.5% | n/a | US$2.9b | US$26.84 | PS1.1x | E94.7% | n/a | Consumer Retailing | ||
SMCI | US$801.61 | -9.9% | 164.6% | US$47.8b | US$1,035.32 | PE44.7x | E40.2% | n/a | Tech | ||
CG | US$45.94 | 6.3% | 32.5% | US$16.7b | US$48.05 | PS7.5x | E23.6% | 3.0% | Diversified Financials | ||
BRDG | US$8.49 | 8.2% | -32.4% | US$1.0b | US$9.88 | PS1.1x | E98.2% | 7.8% | Diversified Financials | ||
DUOL | US$178.57 | -7.3% | 22.2% | US$7.8b | US$252.23 | PE168.8x | E48.1% | n/a | Consumer Services | ||
MAX | US$13.98 | 10.1% | 47.6% | US$923.1m | US$25.33 | PS1.8x | E88.1% | n/a | Media | ||
ZKH | US$3.39 | -11.0% | n/a | US$541.2m | US$15.74 | PB1.2x | E104.4% | n/a | Capital Goods | ||
MDGL | US$279.13 | -3.9% | 30.9% | US$5.7b | US$365.33 | PB7x | E64.4% | n/a | Pharmaceuticals & Biotech | ||
SPRY | US$10.45 | -6.0% | 43.3% | US$1.1b | US$19.00 | PS101207.1x | E57.7% | n/a | Pharmaceuticals & Biotech | ||
SMWB | US$7.30 | 11.5% | 4.9% | US$578.2m | US$10.40 | PS2.6x | E107.1% | n/a | Software | ||
HSCS | US$3.89 | -3.7% | -95.7% | US$2.6m | US$67.50 | PS137.1x | E66.8% | n/a | Healthcare | ||
ALKT | US$32.42 | 6.7% | 97.1% | US$3.2b | US$30.10 | PS11.3x | E92.1% | n/a | Software | ||
EVOK | US$0.55 | -4.4% | -67.9% | US$4.9m | US$7.00 | PB1.3x | E110.6% | n/a | Pharmaceuticals & Biotech | ||
RYAN | US$58.90 | 4.5% | 27.7% | US$15.2b | US$60.08 | PE110.2x | E49.2% | 0.7% | Insurance | ||
NEON | US$3.20 | 41.6% | -25.6% | US$35.2m | US$3.00 | PS11.7x | E158.0% | n/a | Tech | ||
LOOP | US$1.81 | -14.4% | -36.5% | US$93.2m | US$8.50 | PS651.9x | E78.8% | n/a | Materials | ||
ESTA | US$46.44 | 1.8% | -32.5% | US$1.3b | US$64.43 | PS8.2x | E68.2% | n/a | Healthcare | ||
CBNK | US$23.31 | 8.4% | 16.6% | US$331.9m | US$26.38 | PB1.2x | E27.5% | 1.4% | Banks |